These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
45 related items for PubMed ID: 9149907
1. Phosphatidylinositol 3-kinase inhibitor wortmannin blocks mitogenic activation of the transferrin receptor gene promoter in late G1. Miskimins WK, King F, Miskimins R. Cell Growth Differ; 1997 May; 8(5):565-70. PubMed ID: 9149907 [Abstract] [Full Text] [Related]
2. Mitogenic activation of the transferrin receptor gene promoter is modulated by inhibitors of tyrosine kinases and tyrosine phosphatases. Hirsch S, Miskimins R, Miskimins WK. Recept Signal Transduct; 1996 May; 6(3-4):121-9. PubMed ID: 9259047 [Abstract] [Full Text] [Related]
3. Mitogen induction of nuclear factors that interact with a delayed responsive region of the transferrin receptor gene promoter. Hirsch S, Miskimins WK. Cell Growth Differ; 1995 Jun; 6(6):719-26. PubMed ID: 7669727 [Abstract] [Full Text] [Related]
4. The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Price BD, Youmell MB. Cancer Res; 1996 Jan 15; 56(2):246-50. PubMed ID: 8542574 [Abstract] [Full Text] [Related]
5. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L, Matter WF, Dodge J, Grindey G. Cancer Res; 1994 May 01; 54(9):2419-23. PubMed ID: 8162590 [Abstract] [Full Text] [Related]
6. The involvement of phosphatidylinositol 3-kinase in gonadotropin-releasing hormone-induced gonadotropin alpha- and FSHbeta-subunit genes expression in clonal gonadotroph LbetaT2 cells. Mutiara S, Kanasaki H, Harada T, Oride A, Miyazaki K. Mol Cell Endocrinol; 2008 Feb 13; 283(1-2):1-11. PubMed ID: 18206295 [Abstract] [Full Text] [Related]
8. Ultraviolet light and serum induce similar delayed responses that lead to activation of a mitogen-responsive promoter. Hirsch S, Miskimins WK. Cell Mol Biol Res; 1995 Feb 13; 41(5):441-9. PubMed ID: 8867792 [Abstract] [Full Text] [Related]
10. Phosphatidylinositol 3'-kinase, but not p70 ribosomal S6 kinase, is involved in membrane protein recycling: wortmannin inhibits glucose transport and downregulates cell-surface transferrin receptor numbers independently of any effect on fluid-phase endocytosis in fibroblasts. Jess TJ, Belham CM, Thomson FJ, Scott PH, Plevin RJ, Gould GW. Cell Signal; 1996 Jun 13; 8(4):297-304. PubMed ID: 8842531 [Abstract] [Full Text] [Related]
11. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases. Kubota Y, Angelotti T, Niederfellner G, Herbst R, Ullrich A. Cell Growth Differ; 1998 Mar 13; 9(3):247-56. PubMed ID: 9543391 [Abstract] [Full Text] [Related]
12. Epidermal growth factor stimulation of phosphatidylinositol 3-kinase during wound closure in rabbit corneal epithelial cells. Zhang Y, Akhtar RA. Invest Ophthalmol Vis Sci; 1997 May 13; 38(6):1139-48. PubMed ID: 9152233 [Abstract] [Full Text] [Related]
13. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway. Musgrave BL, Phu T, Butler JJ, Makrigiannis AP, Hoskin DW. Exp Cell Res; 1999 Oct 10; 252(1):96-103. PubMed ID: 10502402 [Abstract] [Full Text] [Related]
14. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Goruppi S, Ruaro E, Varnum B, Schneider C. Mol Cell Biol; 1997 Aug 10; 17(8):4442-53. PubMed ID: 9234702 [Abstract] [Full Text] [Related]
15. Choline phosphate and phorbol ester potentiate the mitogenic effect of insulin by competitive mechanisms in NIH 3T3 fibroblasts. Kiss Z, Chung T. Biochem Biophys Res Commun; 1996 Jan 17; 218(2):505-9. PubMed ID: 8561786 [Abstract] [Full Text] [Related]
16. Effects of the protein kinase inhibitors wortmannin and KN62 on cellular radiosensitivity and radiation-activated S phase and G1/S checkpoints in normal human fibroblasts. Enns L, Murray D, Mirzayans R. Br J Cancer; 1999 Nov 17; 81(6):959-65. PubMed ID: 10576651 [Abstract] [Full Text] [Related]
17. In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin. Schultz RM, Merriman RL, Andis SL, Bonjouklian R, Grindey GB, Rutherford PG, Gallegos A, Massey K, Powis G. Anticancer Res; 1995 Nov 17; 15(4):1135-9. PubMed ID: 7653991 [Abstract] [Full Text] [Related]
18. Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. Norman BH, Shih C, Toth JE, Ray JE, Dodge JA, Johnson DW, Rutherford PG, Schultz RM, Worzalla JF, Vlahos CJ. J Med Chem; 1996 Mar 01; 39(5):1106-11. PubMed ID: 8676346 [Abstract] [Full Text] [Related]
19. Inhibitors of phosphoinositide 3-kinase block exocytosis but not endocytosis of transferrin receptors in 3T3-L1 adipocytes. Shepherd PR, Soos MA, Siddle K. Biochem Biophys Res Commun; 1995 Jun 15; 211(2):535-9. PubMed ID: 7794266 [Abstract] [Full Text] [Related]
20. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase. Creemer LC, Kirst HA, Vlahos CJ, Schultz RM. J Med Chem; 1996 Dec 06; 39(25):5021-4. PubMed ID: 8960564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]